{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:35:04Z","timestamp":1766086504333},"reference-count":18,"publisher":"Royal College of Psychiatrists","issue":"3","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":11081,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1987,9]]},"abstract":"<jats:p>In a double-blind study of 38 chronic schizophrenic in-patients, haloperidol decanoate was compared with fluphenazine decanoate as maintenance therapy over 60 weeks. Both drugs were given by injection at 4-week intervals. Haloperidol and fluphenazine were assumed to be equipotent; the mean starting dose of the former was 127 mg and of the latter 106 mg. The number of withdrawals over 60 weeks was similar in both groups but relapses, strictly defined, were significantly more frequent in the haloperidol group. When patients were switched to haloperidol, Parkinsonism diminished more quickly than in the fluphenazine group, but after 60 weeks there was no difference in severity in the two drug groups. The higher relapse rate and the quicker reduction in Parkinsonism in the haloperidol group might be due to a misjudgement in equivalent doses of the two drugs. Plasma haloperidol steady state levels were reached in most patients by 8\u201312 weeks. Plasma neuroleptic and prolactin levels, week-by-week systemic drug availability and Parkinsonism showed less variation between injections with haloperidol than with fluphenazine.<\/jats:p>","DOI":"10.1192\/bjp.151.3.333","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T19:43:23Z","timestamp":1218570203000},"page":"333-336","source":"Crossref","is-referenced-by-count":15,"title":["Haloperidol Decanoate <i>v<\/i>. Fluphenazine Decanoate as Maintenance Therapy in Chronic Schizophrenic In-patients"],"prefix":"10.1192","volume":"151","author":[{"given":"J. P.","family":"McKane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D. T.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. H.","family":"Wiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. G.","family":"McCreadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. S.","family":"Stirling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"S0007125000216644_ref13","first-page":"982","article-title":"Bioavailability and clinical effects of two different concentrations of haloperidol decanoate","volume":"31","author":"Suy","year":"1982","journal-title":"Current Therapeutic Research"},{"key":"S0007125000216644_ref14","doi-asserted-by":"publisher","DOI":"10.1037\/e591322011-001"},{"key":"S0007125000216644_ref1","volume-title":"Haloperidol Update 1958\u20131980","author":"Ayd","year":"1980"},{"key":"S0007125000216644_ref17","first-page":"804","article-title":"A clinical double blind comparison between haloperidol decanoate and fluphenazine decanoate","volume":"35","author":"Wistedt","year":"1984","journal-title":"Current Therapeutic Research"},{"key":"S0007125000216644_ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000468580"},{"key":"S0007125000216644_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1980.tb00621.x"},{"key":"S0007125000216644_ref2","first-page":"662","article-title":"A double-blind trial of haloperidol decanoate and pipothiazine palmitate in the maintenance treatment of schizophrenics in a public out-patient clinic","volume":"37","author":"Bechelli","year":"1985","journal-title":"Current Therapeutic Research"},{"key":"S0007125000216644_ref3","volume-title":"British National Formulary","year":"1984"},{"key":"S0007125000216644_ref4","first-page":"108","article-title":"A double-blind controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia","volume":"20","author":"Chouinard","year":"1984","journal-title":"Psychopharmacology Bulletin"},{"key":"S0007125000216644_ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770070088010"},{"key":"S0007125000216644_ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750190059011"},{"key":"S0007125000216644_ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017373"},{"key":"S0007125000216644_ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb00174.x"},{"key":"S0007125000216644_ref10","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.136.2.146"},{"key":"S0007125000216644_ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb01636.x"},{"key":"S0007125000216644_ref16","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1192\/bjp.107.450.862","article-title":"A simple and reliable subclassification of schizophrenia","volume":"107","author":"Wing","year":"1961","journal-title":"Journal of Mental Science"},{"key":"S0007125000216644_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(77)90011-5"},{"key":"S0007125000216644_ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000216644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T17:43:19Z","timestamp":1558374199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000216644\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,9]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987,9]]}},"alternative-id":["S0007125000216644"],"URL":"https:\/\/doi.org\/10.1192\/bjp.151.3.333","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,9]]}}}